Raymond Scott Turner, MD, PhD - Related publications

1979-1984 Pharmacology Emory University, Atlanta, GA 
 1984-1988 Medicine Emory University, Atlanta, GA 
 1988-1989 Medicine University of Pennsylvania, Philadelphia, PA, United States 
 1989-1995 Neurology University of Pennsylvania, Philadelphia, PA, United States 
 1995-2008 Neurology University of Michigan, Ann Arbor, Ann Arbor, MI 
 2008- Neurology Georgetown University, Washington, DC 
Alzheimer's disease
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Wu S, Liu H, Zhao H, Wang X, Chen J, Xia D, Xiao C, Cheng J, Zhao Z, He Y. Environmental Lead Exposure Aggravates the Progression of Alzheimer's Disease in Mice by Targeting on Blood Brain Barrier. Toxicology Letters. PMID 31730887 DOI: 10.1016/j.toxlet.2019.11.009   
2019 Lu TT, Wan C, Yang W, Cai Z. Role of Cdk5 in Amyloid-beta Pathology of Alzheimer's Disease. Current Alzheimer Research. PMID 31820699 DOI: 10.2174/1567205016666191210094435   
2019 Sho M, Ichiyanagi N, Imaizumi K, Ishikawa M, Morimoto S, Watanabe H, Okano H. A combinational treatment of carotenoids decreases Aβ secretion in human neurons via β-secretase inhibition. Neuroscience Research. PMID 31606373 DOI: 10.1016/j.neures.2019.10.006   
2019 Pulina MV, Hopkins M, Haroutunian V, Greengard P, Bustos V. C99 selectively accumulates in vulnerable neurons in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31677937 DOI: 10.1016/j.jalz.2019.09.002   
2019 Naushad M, Durairajan SSK, Bera AK, Senapati S, Li M. Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease. Planta Medica. PMID 31618777 DOI: 10.1055/a-1019-9819   
2019 Leong YQ, Ng KY, Chye SM, Ling APK, Koh RY. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Metabolic Brain Disease. PMID 31811496 DOI: 10.1007/s11011-019-00516-y   
2019 Zhou R, Yang G, Shi Y. Macromolecular complex in recognition and proteolysis of amyloid precursor protein in Alzheimer's disease. Current Opinion in Structural Biology. 61: 1-8. PMID 31629221 DOI: 10.1016/j.sbi.2019.09.004   
2019 Zhang Z, Shen Q, Wu X, Zhang D, Xing D. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer's disease models. Aging Cell. e13054. PMID 31663252 DOI: 10.1111/acel.13054   
2019 Wu H, Wu ZG, Shi WJ, Gao H, Wu HH, Bian F, Jia PP, Hou YN. Effects of progesterone on glucose uptake in neurons of Alzheimer's disease animals and cell models. Life Sciences. 116979. PMID 31647947 DOI: 10.1016/j.lfs.2019.116979   
2019 Wessels AM, Tariot PN, Zimmer JA, Selzler KJ, Bragg SM, Andersen SW, Landry J, Krull JH, Downing AM, Willis BA, Shcherbinin S, Mullen J, Barker P, Schumi J, Shering C, et al. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials. Jama Neurology. PMID 31764959 DOI: 10.1001/jamaneurol.2019.3988   
2019 Bamford RA, Widagdo J, Takamura N, Eve M, Anggono V, Oguro-Ando A. The Interaction Between Contactin and Amyloid Precursor Protein and Its Role in Alzheimer's Disease. Neuroscience. PMID 31705890 DOI: 10.1016/j.neuroscience.2019.10.006   
2019 Jacob S, Davies G, De Bock M, Hermans B, Wintmolders C, Bottelbergs A, Borgers M, Theunis C, Van Broeck B, Manyakov NV, Balschun D, Drinkenburg WHIM. Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer's disease pathology. Scientific Reports. 9: 16363. PMID 31705038 DOI: 10.1038/s41598-019-51928-w   
2019 Hefter D, Ludewig S, Draguhn A, Korte M. Amyloid, APP, and Electrical Activity of the Brain. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 1073858419882619. PMID 31779518 DOI: 10.1177/1073858419882619   
2019 Sheu JJ, Yang LY, Renuka Sanotra M, Wang ST, Lu HT, Sook Yee Kam R, Hsu IU, Kao SH, Lee CK, Chang-Cheng Shieh J, Lin YF. Reduction of AHI1 in the serum of Taiwanese with probable Alzheimer's disease. Clinical Biochemistry. PMID 31786207 DOI: 10.1016/j.clinbiochem.2019.11.011   
2019 Šimić G, Španić E, Langer Horvat L, Hof PR. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease. Progress in Molecular Biology and Translational Science. 168: 99-145. PMID 31699331 DOI: 10.1016/bs.pmbts.2019.06.003   
2019 Haytural H, Lundgren JL, Köse TB, Jordà-Siquier T, Kalcheva M, Seed Ahmed M, Winblad B, Sundström E, Barthet G, Tjernberg LO, Frykman S. Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies. Frontiers in Aging Neuroscience. 11: 273. PMID 31649526 DOI: 10.3389/fnagi.2019.00273   
2019 García-González L, Pilat D, Baranger K, Rivera S. Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience. 11: 244. PMID 31607898 DOI: 10.3389/fnagi.2019.00244   
2019 Bailey DK, Kosman DJ. Is brain iron trafficking part of the physiology of the amyloid precursor protein? Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. PMID 31578640 DOI: 10.1007/s00775-019-01684-z   
2019 Pendin D, Fasolato C, Basso E, Filadi R, Greotti E, Galla L, Gomiero C, Leparulo A, Redolfi N, Scremin E, Vajente N, Pozzan T, Pizzo P. Familial Alzheimer's disease presenilin-2 mutants affect Ca homeostasis and brain network excitability. Aging Clinical and Experimental Research. PMID 31606858 DOI: 10.1007/s40520-019-01341-0   
2019 Fuchsberger T, Yuste R, Martinez-Bellver S, Blanco-Gandia MC, Torres-Cuevas I, Blasco-Serra A, Arango R, Miñarro J, Rodríguez-Arias M, Teruel-Marti V, Lloret A, Viña J. Oral Monosodium Glutamate Administration Causes Early Onset of Alzheimer's Disease-Like Pathophysiology in APP/PS1 Mice. Journal of Alzheimer's Disease : Jad. PMID 31658055 DOI: 10.3233/JAD-190274   
2019 Metaxas A, Thygesen C, Kempf SJ, Anzalone M, Vaitheeswaran R, Petersen S, Landau AM, Audrain H, Teeling JL, Darvesh S, Brooks DJ, Larsen MR, Finsen B. Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer's disease. Scientific Reports. 9: 15758. PMID 31673052 DOI: 10.1038/s41598-019-52357-5   
2019 Wang X, Wang Y, Zhu Y, Yan L, Zhao L. Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease. Drug Design, Development and Therapy. 13: 4053-4063. PMID 31819374 DOI: 10.2147/DDDT.S233283   
2019 Wang X, Wang Y, Zhu Y, Yan L, Zhao L. Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease. Drug Design, Development and Therapy. 13: 4053-4063. PMID 31819374 DOI: 10.2147/DDDT.S233283   
2019 Huynh TV, Wang C, Tran AC, Tabor GT, Mahan TE, Francis CM, Finn MB, Spellman R, Manis M, Tanzi RE, Ulrich JD, Holtzman DM. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model. Molecular Neurodegeneration. 14: 37. PMID 31623648 DOI: 10.1186/s13024-019-0337-1   
2019 Kim DK, Han D, Park J, Choi H, Park JC, Cha MY, Woo J, Byun MS, Lee DY, Kim Y, Mook-Jung I. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease. Experimental & Molecular Medicine. 51: 136. PMID 31727875 DOI: 10.1038/s12276-019-0326-z   
2019 Jacob RS, Anoop A, Maji SK. Protein Nanofibrils as Storage Forms of Peptide Drugs and Hormones. Advances in Experimental Medicine and Biology. 1174: 265-290. PMID 31713202 DOI: 10.1007/978-981-13-9791-2_8   
2019 Michelson D, Grundman M, Magnuson K, Fisher R, Levenson JM, Aisen P, Marek K, Gray M, Hefti F. Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer's Disease. The Journal of Prevention of Alzheimer's Disease. 6: 228-231. PMID 31686093 DOI: 10.14283/jpad.2019.37   
2019 Hata S, Omori C, Kimura A, Saito H, Kimura N, Gupta V, Pedrini S, Hone E, Chatterjee P, Taddei K, Kasuga K, Ikeuchi T, Waragai M, Nishimura M, Hu A, et al. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 740-750. PMID 31754625 DOI: 10.1016/j.trci.2019.09.015   
2019 Paasila PJ, Davies DS, Kril JJ, Goldsbury C, Sutherland GT. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology. Brain Pathology (Zurich, Switzerland). 29: 726-740. PMID 30803086 DOI: 10.1111/bpa.12717   
2019 Philip AT, Devkota S, Malvankar S, Bhattarai S, Meneely KM, Williams TD, Wolfe MS. Designed helical peptides as functional probes for γ-secretase. Biochemistry. PMID 31625391 DOI: 10.1021/acs.biochem.9b00639   
2019 Shin WS, Di J, Cao Q, Li B, Seidler PM, Murray KA, Bitan G, Jiang L. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation. Alzheimer's Research & Therapy. 11: 86. PMID 31627745 DOI: 10.1186/s13195-019-0541-9   
2019 Gourmaud S, Shou H, Irwin DJ, Sansalone K, Jacobs LM, Lucas TH, Marsh ED, Davis KA, Jensen FE, Talos DM. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy. Brain : a Journal of Neurology. PMID 31834353 DOI: 10.1093/brain/awz381   
2019 Wang ZJ, Zhao F, Wang CF, Zhang XM, Xiao Y, Zhou F, Wu MN, Zhang J, Qi JS, Yang W. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31683484 DOI: 10.3233/JAD-190796   
2019 Iqbal K, Liu F, Gong C, Dai C, Hu W. Why delay in effective treatment for Alzheimer's disease and related conditions. Progress in Molecular Biology and Translational Science. 168: 243-256. PMID 31699318 DOI: 10.1016/bs.pmbts.2019.08.002   
2019 Ben-Nejma IRH, Keliris AJ, Daans J, Ponsaerts P, Verhoye M, Van der Linden A, Keliris GA. Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis. Acta Neuropathologica Communications. 7: 180. PMID 31727182 DOI: 10.1186/s40478-019-0810-7   
2019 Thal DR, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, et al. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia. Acta Neuropathologica Communications. 7: 178. PMID 31727169 DOI: 10.1186/s40478-019-0837-9   
2019 Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in Alzheimer's disease. Experimental Neurology. 113112. PMID 31730762 DOI: 10.1016/j.expneurol.2019.113112   
2019 Li TR, Wang XN, Sheng C, Li YX, Li FZ, Sun Y, Han Y. Extracellular vesicles as an emerging tool for the early detection of Alzheimer's disease. Mechanisms of Ageing and Development. 111175. PMID 31678325 DOI: 10.1016/j.mad.2019.111175   
2019 Chen L, Xu S, Wu T, Shao Y, Luo L, Zhou L, Ou S, Tang H, Huang W, Guo K, Xu J. Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice. Aging. 11. PMID 31744937 DOI: 10.18632/aging.102451   
2019 Wang S, Lin B, Lin G, Sun C, Lin R, Huang J, Tao J, Wang X, Wu Y, Chen L, Chen J. Label-free multiphoton imaging of -amyloid plaques in Alzheimer's disease mouse models. Neurophotonics. 6: 045008. PMID 31737743 DOI: 10.1117/1.NPh.6.4.045008   
2019 Liu PP, Xie Y, Meng XY, Kang JS. History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal Transduction and Targeted Therapy. 4: 29. PMID 31637009 DOI: 10.1038/s41392-019-0063-8   
2019 Wang Z, Cao M, Xiang H, Wang W, Feng X, Yang X. WBQ5187, a Multitarget, Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease and Modulates Cerebral β-amyloid, Gliosis, cAMP Levels and Neurodegeneration. Acs Chemical Neuroscience. PMID 31697472 DOI: 10.1021/acschemneuro.9b00409   
2019 Jokar S, Khazaei S, Behnammanesh H, Shamloo A, Erfani M, Beiki D, Bavi O. Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer's disease therapy. Biophysical Reviews. PMID 31713720 DOI: 10.1007/s12551-019-00606-2   
2019 Sushma, Mondal AC. Role of GPCR signaling and calcium dysregulation in Alzheimer's disease. Molecular and Cellular Neurosciences. 103414. PMID 31655116 DOI: 10.1016/j.mcn.2019.103414   
2019 Pires G, McElligott S, Drusinsky S, Halliday G, Potier MC, Wisniewski T, Drummond E. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies. Acta Neuropathologica Communications. 7: 195. PMID 31796108 DOI: 10.1186/s40478-019-0848-6   
2019 Vander Zanden CM, Chi EY. Passive immunotherapies targeting amyloid beta and tau oligomers in Alzheimer's disease. Journal of Pharmaceutical Sciences. PMID 31647950 DOI: 10.1016/j.xphs.2019.10.024   
2019 Joshi P, Kawade V, Dhulap S, Goel M. Unlocking the concealed targets using system biology mapping for Alzheimer's disease. Pharmacological Reports : Pr. 71: 1104-1107. PMID 31634797 DOI: 10.1016/j.pharep.2019.06.012   
2019 Zhuang L, Peng F, Huang Y, Li W, Huang J, Chu Y, Ren P, Sun Y, Zhang Y, Xue E, Guo X, Shen X, Xue L. CHIP modulates APP-induced autophagy-dependent pathological symptoms in Drosophila. Aging Cell. e13070. PMID 31777182 DOI: 10.1111/acel.13070   
2019 Pérez-Grijalba V, Arbizu J, Romero J, Prieto E, Pesini P, Sarasa L, Guillen F, Monleón I, San-José I, Martínez-Lage P, Munuera J, Hernández I, Buendía M, Sotolongo-Grau O, Alegret M, ... , et al. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study. Alzheimer's Research & Therapy. 11: 96. PMID 31787105 DOI: 10.1186/s13195-019-0549-1   
2019 Singh A, Agarwal S, Singh S. Age related neurodegenerative Alzheimer's disease: Usage of traditional herbs in therapeutics. Neuroscience Letters. 134679. PMID 31816333 DOI: 10.1016/j.neulet.2019.134679